7 August 2025 - The scheme will be launched on 1 January 2026 and is expected to provide access to treatments for serious or life-threatening diseases even before they are officially authorised for the European market.

Since 2022, under the leadership of the NIHDI (National Institute for Health and Disability Insurance) and Federal Health Minister Frank Vandenbroucke, a major reform of the medical reimbursement system has been underway. 

It includes various elements, from greater transparency in contracts with pharmaceutical companies to better integration of patients in the decision-making process, as well as modernising reimbursement procedures.

Read The Brussels Times article